Lymphocyte Immunization Therapy (LIT) in Noida Understanding LIT as an experimental immune-related fertility treatment and when evidence-based fertility evaluation should come first
If you have experienced recurrent pregnancy loss, repeated unsuccessful embryo transfers, or failed IVF treatment, you may have come across Lymphocyte Immunization Therapy (LIT) while researching fertility immunology treatments.
What is Lymphocyte Immunization Therapy (LIT)?
Lymphocyte Immunization Therapy, commonly called LIT, is an immune-based treatment that has been proposed for women experiencing recurrent pregnancy loss or implantation failure.
The treatment involves obtaining lymphocytes, a type of white blood cell, usually from the male partner or another source according to the protocol being used. These lymphocytes are processed and then introduced into the female partner with the proposed intention of changing the maternal immune response.
However, this proposed mechanism has not translated into sufficiently reliable evidence of improved live-birth outcomes. For this reason, LIT is not regarded as a standard fertility treatment.
At Divine IVF, Sector 76, Noida, Dr. Mandavi Rai provides personalised fertility evaluation for recurrent pregnancy loss, implantation concerns and previous IVF failure. Lymphocyte Immunization Therapy is not considered a routine evidence-based fertility treatment. Major reproductive-medicine guidelines do not recommend its routine use for unexplained recurrent pregnancy loss because a meaningful clinical benefit has not been established and potential adverse effects exist.
How it works
Step 1 – Blood Collection
Blood may be collected from the male partner or another source according to the protocol.
Step 2 – Lymphocyte Separation
White blood cells, including lymphocytes, are isolated from the blood sample.
Step 3 – Preparation
The lymphocytes undergo laboratory preparation.
Step 4 – Administration
Prepared lymphocytes may be introduced through injections into the female patient.
Step 5 – Repeat Treatment
Some historical protocols have involved more than one treatment session. There is no universally accepted evidence-based fertility protocol because LIT is not a routine recommended therapy.
Benefits
- Currently, there are no proven benefits of LIT for unexplained recurrent pregnancy loss or implantation failure that are supported by major reproductive-medicine guidelines.
- ESHRE specifically recommends that LIT should not be used as treatment for unexplained recurrent pregnancy loss because a significant beneficial effect has not been established and serious adverse effects may occur.
- Patients should be aware that LIT is not considered a standard evidence-based fertility treatment.
Things to know
- It is not considered a standard evidence-based fertility treatment
- Major reproductive-medicine guidelines do not recommend its routine use for unexplained recurrent pregnancy loss
- A meaningful clinical benefit has not been established
- Potential adverse effects exist
- ESHRE recommends against its use due to lack of proven benefit and potential serious adverse effects
- Studies have produced inconsistent findings and have had methodological limitations
- There is no universally accepted evidence-based fertility protocol
- Patients should not be told that LIT is proven to increase pregnancy rates
Getting ready
Before considering any experimental immune treatment, patients with recurrent miscarriage or failed implantation should receive a structured evaluation. This may include pregnancy history review, genetic assessment, uterine evaluation, antiphospholipid syndrome testing, thyroid and other medical condition assessment, and IVF and embryo history review.
Patients should understand that LIT is not a routine evidence-based fertility treatment. Major reproductive-medicine guidelines do not recommend its routine use for unexplained recurrent pregnancy loss because a meaningful clinical benefit has not been established and potential adverse effects exist.
Dr. Rai will review your complete fertility history, previous pregnancy losses, and any previous treatment outcomes before discussing whether any experimental therapy might be considered.
What to expect
Patients considering LIT should first undergo a structured evaluation to identify recognised causes of pregnancy loss or failed implantation. If LIT is being considered, patients should receive clear counselling about the experimental nature of the treatment, the lack of proven benefit, and the potential risks. Dr. Rai will explain the specific reasoning and process for your case, since this therapy is only considered after individual evaluation and with full understanding of the limitations.
Lymphocyte Immunization Therapy (LIT) in Noida
Understanding LIT as an experimental immune-related fertility treatment and when evidence-based fertility evaluation should come first.
📍 Sector 76, Noida, Uttar Pradesh
📞 Call: +91 7678451808
What Is Lymphocyte Immunization Therapy?
Lymphocyte Immunization Therapy, commonly called LIT, is an immune-based treatment that has been proposed for women experiencing recurrent pregnancy loss or implantation failure.
The treatment involves obtaining lymphocytes, a type of white blood cell, usually from the male partner or another source according to the protocol being used.
These lymphocytes are processed and then introduced into the female partner with the proposed intention of changing the maternal immune response.
However, this proposed mechanism has not translated into sufficiently reliable evidence of improved live-birth outcomes. For this reason, LIT is not regarded as a standard fertility treatment.
Understanding LIT
What Does LIT Stand For?
LIT stands for Lymphocyte Immunization Therapy. You may also see related terms such as Lymphocyte Immunotherapy, Partner Lymphocyte Immunization, Paternal Lymphocyte Immunization, or Lymphocyte Immunization for Recurrent Miscarriage. These terms generally describe immune-modulating approaches involving lymphocytes.
Why Has LIT Been Proposed in Fertility Treatment?
LIT was developed around theories that some miscarriages or implantation failures may involve an abnormal maternal immune response. The proposed idea was that exposure to lymphocytes from the male partner might help modify the woman`s immune response to pregnancy.
However, reproduction and maternal-fetal immune tolerance are complex. Current scientific evidence has not established LIT as an effective routine treatment for recurrent miscarriage.
Is LIT an IVF Treatment?
No.
LIT is not part of the standard IVF procedure. Standard IVF generally involves ovarian stimulation, egg retrieval, fertilisation, embryo culture, and embryo transfer. LIT has instead been proposed as an immune-related treatment add-on for selected patients with histories such as repeated pregnancy loss or unsuccessful embryo transfers. It should not be confused with IVF, ICSI, embryo transfer or genetic testing.
LIT for Recurrent Pregnancy Loss
Recurrent pregnancy loss can have many possible causes. These may include:
In some cases, no definite cause is identified. LIT has historically been proposed for unexplained recurrent pregnancy loss, but current major guidelines do not support its routine clinical use.
What Is Recurrent Pregnancy Loss?
Recurrent pregnancy loss generally refers to repeated spontaneous pregnancy losses. Modern clinical evaluation may begin after two pregnancy losses depending on the patient`s history and clinical circumstances. A structured evaluation can help identify potentially treatable causes before unproven immune therapies are considered.
LIT for Implantation Failure and Failed IVF
LIT for Recurrent Implantation Failure
Some patients with repeated unsuccessful embryo transfers may search for immune therapies such as LIT. However, implantation failure may involve multiple factors. These include embryo chromosomal abnormalities, embryo quality, female age, uterine abnormalities, endometrial preparation, hydrosalpinx, transfer-related factors, male fertility factors, and other medical conditions.
LIT should not replace investigation of these recognised factors.
LIT After Failed IVF
An unsuccessful IVF cycle does not automatically indicate an immune disorder. After failed IVF, the treatment cycle should be reviewed carefully.
Important areas include:
Only after reviewing these factors should additional investigations be considered.
The Immune System and Pregnancy
Does the Immune System Affect Pregnancy?
Yes, the immune system plays an important role in pregnancy. However, this does not mean that immune abnormalities are the cause of every miscarriage or failed embryo transfer.
The maternal immune system interacts with the developing embryo, placental tissue, the endometrium, and various immune-cell populations. This relationship is complex and still an active area of research.
Therefore, broad immune treatments should not be assumed to improve fertility simply because the immune system is involved in pregnancy.
Natural Killer Cells and LIT
Some fertility immunology approaches focus on Natural Killer (NK) cells. NK cells are normal immune cells and are naturally present within the uterus.
However:
- Blood NK-cell measurements may not reflect uterine immune activity
- NK-cell testing lacks standardisation
- The relationship between NK-cell levels and pregnancy loss is not fully established
- An abnormal immune test does not automatically mean LIT is required
ASRM currently does not recommend routine immune testing and treatment in recurrent pregnancy loss.
How Has LIT Traditionally Been Performed?
Protocols vary and LIT is not standard fertility therapy.
Historically, treatment approaches have involved steps such as:
- Blood Collection — Blood may be collected from the male partner or another source according to the protocol
- Lymphocyte Separation — White blood cells, including lymphocytes, are isolated from the blood sample
- Preparation — The lymphocytes undergo laboratory preparation
- Administration — Prepared lymphocytes may be introduced through injections into the female patient
- Repeat Treatment — Some historical protocols have involved more than one treatment session
There is no universally accepted evidence-based fertility protocol because LIT is not a routine recommended therapy.
Does LIT Improve Fertility Outcomes?
Does LIT Improve Pregnancy Rate?
Current evidence is insufficient to establish LIT as an effective way of improving pregnancy or live-birth outcomes in women with unexplained recurrent pregnancy loss.
Studies have produced inconsistent findings and have had methodological limitations. Therefore, patients should not be told that LIT is proven to increase pregnancy rates.
Does LIT Prevent Miscarriage?
There is currently no reliable evidence that LIT prevents miscarriage in women with unexplained recurrent pregnancy loss.
ESHRE specifically recommends that LIT should not be used as treatment for unexplained recurrent pregnancy loss because a significant beneficial effect has not been established and serious adverse effects may occur.
Does LIT Improve IVF Success?
LIT has not been established as a proven method for improving IVF success. IVF outcome depends on multiple factors including female age, egg quality, sperm quality, embryo development, chromosomal status, uterine health, endometrial preparation, and underlying infertility diagnosis.
LIT cannot correct these factors.
Is LIT Recommended After Repeated Embryo Transfer Failure?
Routine LIT is not recommended simply because multiple embryo transfers have failed.
A structured evaluation should first review:
Optional or experimental treatments should only be considered after patients understand the uncertainty of benefit.
Risks and Controversy of LIT
Risks and Possible Side Effects of LIT
LIT involves exposure to human immune cells and therefore has potential risks. Depending on the preparation and administration method, possible concerns can include injection-site reactions, pain, swelling, redness, fever or systemic reactions, allergic reactions, infection transmission risk, immune sensitisation, and other immunological complications.
ESHRE notes that there may be serious adverse effects and recommends against its use for unexplained recurrent pregnancy loss.
Why Is LIT Controversial?
LIT remains controversial because:
- Its proposed immune mechanism is not fully established
- Studies have produced inconsistent results
- Clinical protocols are not standardised
- Immune testing methods vary
- Reliable live-birth benefit has not been demonstrated
- Potential adverse effects exist
- Major reproductive guidelines do not recommend routine use
LIT vs Other Immune Therapies
LIT vs Intralipid Therapy
Both LIT and intralipid therapy have been proposed as immune-related fertility treatments, but they are completely different. LIT uses prepared lymphocytes with the aim of modifying the maternal immune response. Intralipid therapy uses an intravenous lipid emulsion that has been proposed to influence immune activity. Neither treatment is established as a routine therapy for unexplained recurrent pregnancy loss.
LIT vs IVIG
LIT uses lymphocytes for immune exposure. IVIG (Intravenous Immunoglobulin) is a blood-derived immunoglobulin preparation used for certain medical immune conditions. Neither should automatically be used as a fertility add-on for unexplained recurrent miscarriage.
What Should Be Checked Before Considering Immune Therapy?
Before considering any experimental immune treatment, patients with recurrent miscarriage or failed implantation should receive a structured evaluation.
Pregnancy History
The number, timing and nature of previous pregnancy losses are reviewed.
Genetic Factors
Genetic assessment may be appropriate depending on the clinical history. Testing pregnancy-loss tissue can also provide useful information in selected circumstances.
Uterine Evaluation
Assessment may help identify fibroids, polyps, uterine septum, adhesions, or other structural abnormalities.
Antiphospholipid Syndrome
Appropriate testing may be recommended when clinically indicated.
Thyroid and Other Medical Conditions
Relevant endocrine or systemic conditions should be assessed and managed appropriately.
IVF and Embryo History
For patients who have undergone IVF, previous embryo-development and transfer results should be reviewed.
What Treatments Are Used for Recurrent Pregnancy Loss?
Treatment depends on the diagnosed cause. Examples can include:
- Management of identified uterine abnormalities
- Treatment according to established protocols for antiphospholipid syndrome
- Management of thyroid or other medical conditions
- Genetic counselling when indicated
- IVF/PGT in selected genetic situations
- Appropriate pregnancy monitoring
When no cause is identified, patients should receive counselling about the uncertainty surrounding many empirical treatments.
Is LIT Approved as Standard Fertility Treatment?
LIT is not considered a standard routine treatment supported by current major reproductive-medicine guidelines for unexplained recurrent pregnancy loss.
Patients should carefully evaluate claims made by any clinic offering it. Important questions include:
- What guideline supports treatment?
- What evidence shows improved live birth?
- What risks are involved?
- Is the treatment being performed as part of a research protocol?
- What alternatives are available?
Lymphocyte Immunization Therapy Cost in Noida
The LIT treatment cost in Noida can vary depending on the provider, laboratory preparation, number of sessions and associated investigations.
However, cost should not be the first consideration.
Before paying for LIT, patients should ask:
Because LIT is not a routine guideline-supported therapy for unexplained recurrent pregnancy loss, patients should receive clear counselling before considering treatment.
Questions to Ask Before LIT Treatment
Before considering LIT, ask your fertility specialist:
Why Choose Divine IVF for Recurrent Pregnancy Loss Evaluation
- ✓Structured Fertility Evaluation — Repeated pregnancy loss or implantation failure should first be investigated for recognised reproductive and medical causes.
- ✓Review of Previous IVF Treatment — Previous embryo development, transfers and treatment protocols can be reviewed before additional therapy is considered.
- ✓Genetic and Uterine Factors — Appropriate assessment for genetic, uterine and other fertility-related factors can be discussed.
- ✓Evidence-Based Fertility Counselling — Patients should be informed when treatments have limited or uncertain supporting evidence.
- ✓IVF and Advanced Fertility Care — Depending on the diagnosis, evidence-based fertility options such as IVF, ICSI, embryo transfer and genetic testing can be discussed when appropriate.
- ✓Doctor-Led Fertility Care — Evaluation and fertility treatment planning are provided under the guidance of Dr. Mandavi Rai, Gynecologist & IVF Specialist in Noida.
- ✓Convenient Location in Sector 76, Noida — Divine IVF is located in Sector 76, Noida, for patients seeking fertility evaluation after miscarriage, implantation failure or previous unsuccessful IVF treatment.
Book a Recurrent Pregnancy Loss Consultation in Noida
If you have experienced repeated miscarriages, implantation failure or unsuccessful IVF treatment and are considering LIT or another immune therapy, begin with a detailed fertility evaluation. At Divine IVF, Sector 76, Noida, Dr. Mandavi Rai provides personalised assessment to identify recognised fertility, genetic, uterine and medical factors before discussing additional treatments.
Divine IVF · Sector 76, Noida, Uttar Pradesh
Resources
Common questions
LIT stands for Lymphocyte Immunization Therapy.
LIT is an immune-based therapy in which lymphocytes are prepared and administered with the proposed aim of modifying maternal immune responses.
It has historically been proposed for recurrent miscarriage, but current major guidelines do not recommend it for unexplained recurrent pregnancy loss.
A reliable miscarriage-prevention benefit has not been established.
There is insufficient evidence to consider LIT a proven treatment for increasing IVF success or live birth.
No. Failed embryo transfer should first be evaluated for embryo, uterine, endometrial and other recognised fertility factors.
LIT has been discussed within reproductive-immunology approaches, but routine NK-cell testing and immune treatments are not supported by sufficient evidence.
Possible concerns include injection reactions, infection transmission, immune sensitisation and other adverse immune effects.
No. LIT involves lymphocytes, while intralipid therapy involves intravenous fat emulsion.
No. IVIG contains immunoglobulins, while LIT involves lymphocyte immunisation.
Not automatically. A structured recurrent pregnancy-loss assessment should be performed before considering experimental therapies.
No.
Costs can vary, but patients should first establish whether there is a scientifically supported indication for treatment.
You can consult Dr. Mandavi Rai at Divine IVF, Sector 76, Noida for evaluation of recurrent pregnancy loss, IVF failure and related fertility concerns.
Ready to talk to Dr. Mandavi Rai?
Bring your questions, your history, and your pace — we`ll build the next step together.